ArticleEuropean radiology experimental2026
TACE plus donafenib and immune checkpoint inhibitors for intermediate HCC (CHANCE2410 study): a propensity score matching analysis.
Rong Ding et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.